Xu Y, Bhargava G, Wu H, Loeber G, Tong L
Department of Biological Sciences, Columbia University, New York, NY 10027, USA.
Structure. 1999 Aug 15;7(8):R877-89.
Malic enzymes catalyze the oxidative decarboxylation of malate to pyruvate and CO2 with the concomitant reduction of NAD(P)+ to NAD(P)H. They are widely distributed in nature and have important biological functions. Human mitochondrial NAD(P)+-dependent malic enzyme (mNAD-ME) may have a crucial role in the metabolism of glutamine for energy production in rapidly dividing cells and tumors. Moreover, this isoform is unique among malic enzymes in that it is a cooperative enzyme, and its activity is controlled allosterically.
The crystal structure of human mNAD-ME has been determined at 2.5 A resolution by the selenomethionyl multiwavelength anomalous diffraction method and refined to 2.1 A resolution. The structure of the monomer can be divided into four domains; the active site of the enzyme is located in a deep cleft at the interface between three of the domains. Three acidic residues (Glu255, Asp256 and Asp279) were identified as ligands for the divalent cation that is required for catalysis by malic enzymes.
The structure reveals that malic enzymes belong to a new class of oxidative decarboxylases. The tetramer of the enzyme appears to be a dimer of dimers. The active site of each monomer is located far from the tetramer interface. The structure also shows the binding of a second NAD+ molecule in a pocket 35 A away from the active site. The natural ligand for this second binding site may be ATP, an allosteric inhibitor of the enzyme.
苹果酸酶催化苹果酸氧化脱羧生成丙酮酸和二氧化碳,同时将NAD(P)+还原为NAD(P)H。它们在自然界中广泛分布并具有重要的生物学功能。人线粒体NAD(P)+依赖性苹果酸酶(mNAD-ME)在快速分裂的细胞和肿瘤中谷氨酰胺代谢以供能方面可能起关键作用。此外,这种同工型在苹果酸酶中是独特的,因为它是一种协同酶,其活性受别构调控。
通过硒代甲硫氨酸多波长反常衍射法,已确定人mNAD-ME的晶体结构,分辨率为2.5 Å,并精修至2.1 Å分辨率。单体结构可分为四个结构域;酶的活性位点位于三个结构域之间界面处的一个深裂隙中。三个酸性残基(Glu255、Asp256和Asp279)被确定为苹果酸酶催化所需二价阳离子的配体。
该结构表明苹果酸酶属于一类新的氧化脱羧酶。该酶的四聚体似乎是二聚体的二聚体。每个单体的活性位点远离四聚体界面。该结构还显示了第二个NAD+分子在距活性位点35 Å处的一个口袋中的结合。这个第二个结合位点的天然配体可能是ATP,该酶的一种别构抑制剂。